Cyclin B2 (CCNB2) Stimulates the Proliferation of Triple-Negative Breast Cancer (TNBC) Cells In Vitro and In Vivo

Triple-negative breast cancer (TNBC) is the most aggressive type of breast cancer. Currently, targeting therapy makes great advances for the treatment of TNBC, whereas more effective therapeutic targets are urgently needed. Cyclin B2 (CCNB2), which belongs to B-type cyclins, is known as a cell cycle...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Shuai, Su, Rui, Jia, Hongyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8331305/
https://www.ncbi.nlm.nih.gov/pubmed/34354775
http://dx.doi.org/10.1155/2021/5511041

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8331305/
https://www.ncbi.nlm.nih.gov/pubmed/34354775
http://dx.doi.org/10.1155/2021/5511041

Ejemplares similares